BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18365016)

  • 1. Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury.
    Siegel M; Strnad P; Watts RE; Choi K; Jabri B; Omary MB; Khosla C
    PLoS One; 2008 Mar; 3(3):e1861. PubMed ID: 18365016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and inhibition of transglutaminase 2 in mice.
    Dafik L; Albertelli M; Stamnaes J; Sollid LM; Khosla C
    PLoS One; 2012; 7(2):e30642. PubMed ID: 22319575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.
    Plugis NM; Palanski BA; Weng CH; Albertelli M; Khosla C
    J Biol Chem; 2017 Feb; 292(5):2000-2008. PubMed ID: 28003361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of extracellular transglutaminase 2 by thioredoxin.
    Jin X; Stamnaes J; Klöck C; DiRaimondo TR; Sollid LM; Khosla C
    J Biol Chem; 2011 Oct; 286(43):37866-73. PubMed ID: 21908620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β
    Vyas FS; Nelson CP; Freeman F; Boocock DJ; Hargreaves AJ; Dickenson JM
    Eur J Pharmacol; 2017 Oct; 813():105-121. PubMed ID: 28754379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unprecedented dual antagonist and agonist of human Transglutaminase 2.
    Yi MC; Palanski BA; Quintero SA; Plugis NM; Khosla C
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4922-4926. PubMed ID: 26004580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A1 adenosine receptor-induced phosphorylation and modulation of transglutaminase 2 activity in H9c2 cells: A role in cell survival.
    Vyas FS; Hargreaves AJ; Bonner PL; Boocock DJ; Coveney C; Dickenson JM
    Biochem Pharmacol; 2016 May; 107():41-58. PubMed ID: 27005940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of transglutaminase 2 in PAC
    Algarni AS; Hargreaves AJ; Dickenson JM
    Biochem Pharmacol; 2017 Mar; 128():55-73. PubMed ID: 28065858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
    Algarni AS; Hargreaves AJ; Dickenson JM
    Eur J Pharmacol; 2018 Feb; 820():113-129. PubMed ID: 29242118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J; Cardoso I; Iversen R; Sollid LM
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2.
    Dafik L; Khosla C
    Chem Biol; 2011 Jan; 18(1):58-66. PubMed ID: 21276939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive Binding of Magnesium to Calcium Binding Sites Reciprocally Regulates Transamidase and GTP Hydrolysis Activity of Transglutaminase 2.
    Jeong EM; Lee KB; Kim GE; Kim CM; Lee JH; Kim HJ; Shin JW; Kwon MA; Park HH; Kim IG
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2.
    Choi K; Siegel M; Piper JL; Yuan L; Cho E; Strnad P; Omary B; Rich KM; Khosla C
    Chem Biol; 2005 Apr; 12(4):469-75. PubMed ID: 15850984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of tissue transglutaminase.
    Keillor JW; Apperley KY; Akbar A
    Trends Pharmacol Sci; 2015 Jan; 36(1):32-40. PubMed ID: 25500711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of the ex vivo transglutaminase activity in liver macrophages of sepsis mice.
    Su T; Qin XY; Furutani Y; Yu W; Kojima S
    Anal Biochem; 2020 May; 597():113654. PubMed ID: 32142762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
    Badarau E; Wang Z; Rathbone DL; Costanzi A; Thibault T; Murdoch CE; El Alaoui S; Bartkeviciute M; Griffin M
    Chem Biol; 2015 Oct; 22(10):1347-61. PubMed ID: 26456735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase 2 Facilitates Murine Wound Healing in a Strain-Dependent Manner.
    Yiu TW; Holman SR; Kaidonis X; Graham RM; Iismaa SE
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
    Fisher ML; Keillor JW; Xu W; Eckert RL; Kerr C
    Mol Cancer Res; 2015 Jul; 13(7):1083-94. PubMed ID: 25934691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular transglutaminase 2 induces myotube hypertrophy through G protein-coupled receptor 56.
    Kitakaze T; Yoshikawa M; Kobayashi Y; Kimura N; Goshima N; Ishikawa T; Ogata Y; Yamashita Y; Ashida H; Harada N; Yamaji R
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118563. PubMed ID: 31666191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.